Silver Book Fact

A blood thinning drug was found to reduce the risk of heart attack, stroke, and cardiovascular disease by 20% in patients with acute coronary syndrome when given in addition to aspirin.

Salim, Yusuf, D. Phil, Feng Zhao, Shamir R. Mehta, Susan Chrolavicius, Gianni Tognoni, and Keith K. Fox. Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation. N Engl J Med. 2001; 345(7): 494-502. http://content.nejm.org/cgi/content/abstract/345/7/494

Reference

Title
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
Publication
N Engl J Med
Publication Date
2001
Authors
Salim, Yusuf, D. Phil, Feng Zhao, Shamir R. Mehta, Susan Chrolavicius, Gianni Tognoni, and Keith K. Fox
Volume & Issue
Volume 345, Issue 7
Pages
494-502
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Ischemic stroke patients treated with t-PA (a drug used to treat blood clots) within 3 hours of onset are 33% more likely to be free of disability 3 months after…  
  • Stroke prevention through optimal anticoagulation
    If half of atrial fibrillation patients who currently receive warfarin in a routine care setting had their anti-coagulation optimized, around 9,000 strokes and more than 29,000 bleeds would be prevented.  
  • The projected economic value of eliminating deaths from stroke is $7.6 trillion.  
  • The projected economic value of eliminating deaths from heart disease is approximately $48 trillion.  
  • Death rates from heart disease and stroke are falling in-part because of new drug treatments. According to the National Heart, Lung and Blood Institute, if death rates were the same…